Suchergebnisse - "Gatesman, Taylor A"

PubPharm (8)

1

Characterization of low-grade epilepsy-associated tumor from implanted stereoelectroencephalography electrodes

enthalten in: Epilepsia open | 2024

von Gatesman, T. | Hect, J. | Phillips, H. | +8

2

An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma

enthalten in: Cell reports | 2024

von Casillo, S. | Gatesman, T. | Chilukuri, A. | +41

3

Characterization of low‐grade epilepsy‐associated tumor from implanted stereoelectroencephalography electrodes

enthalten in: Epilepsia Open | 2024

von Gatesman, T. | Hect, J. | Phillips, H. | +8

4

Targeting mitochondrial energetics reverses panobinostat- and marizomib-induced resistance in pediatric and adult high-grade gliomas

enthalten in: Molecular oncology | 2023

von Jane, E. | Reslink, M. | Gatesman, T. | +14

5

Targeting mitochondrial energetics reverses panobinostat‐ and marizomib‐induced resistance in pediatric and adult high‐grade gliomas

enthalten in: Molecular Oncology | 2023

von Jane, E. | Reslink, M. | Gatesman, T. | +14

6

The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location

enthalten in: Nature genetics | 2022

von Liu, I. | Jiang, L. | Samuelsson, E. | +43

7

Author Correction : Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

enthalten in: Nature cancer | 2022

von Golbourn, B. | Halbert, M. | Halligan, K. | +46

ErratumFor: Nat Cancer. 2022 May;3(5):629-648. - PMID 35422502

8

Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

enthalten in: Nature cancer | 2022

von Golbourn, B. | Halbert, M. | Halligan, K. | +46

ErratumIn: Nat Cancer. 2022 Jun 23;:. - PMID 35739422

1
[1]